CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-30 | Christenson Johan Director | Grant or award · Stock Option (right to Buy) | +5,600 | 5,600 | ||
| 2019-10-07 | Christenson Johan Director | Conversion | +1,661,382 | 1,671,941 | ||
| 2019-10-07 | Christenson Johan Director | Conversion | +427,496 | 2,099,437 | ||
| 2019-10-07 | Christenson Johan Director | Purchase | +266,667 | $15.00 | $4.0M | 2,366,104 |
| 2019-10-07 | Christenson Johan Director | Conversion · Series B Convertible Preferred Stock | −1,661,382 | 0 | ||
| 2019-10-07 | Christenson Johan Director | Conversion · Series C Convertible Preferred Stock | −427,496 | 0 |
Page 1 of 1 · 6 trades